Purchase of Euromedic International receives clearance from competition authorities and completes


London, 16th December, 2014: Waypoint Capital (“Waypoint”) and Euromedic International (“Euromedic” or “the Company”) have received competition clearance from the Turkish and Polish authorities allowing for the completion of the recent transaction which will see Waypoint take full responsibility for Euromedic.

Euromedic has also appointed Richard Smith as non-executive Chairman, effective from 16th December 2014.

Richard was most recently CEO of Integrated Dental Holdings, having previously worked for Lloyds Pharmacy (part of the Celesio Health Group) as Managing Director. He began his career at Unilever before spending over 30 years working in a series of roles across customer service, multisite operations management, marketing, finance and operations, notably at Somerfield Stores plc.

Stefan Meister, Waypoint Group COO, said: “Richard Smith is an excellent addition to the Euromedic team. This is a business with strong growth potential and his experience in key areas such as customer service, multisite operations management, marketing and strategy development will be invaluable as Euromedic works to deliver its full potential. With the clearance from Turkey and Poland now received, we have completed our acquisition and look forward to seeing Euromedic tackle the next stage of its development.”

Richard Smith said: “Developing world class healthcare is my passion, so I am delighted to have this opportunity to work with the excellent team at Euromedic and help them continue to build this great business into an even more exciting and unique healthcare provider.”